Today, the GenoMed4All project officially ends… but its legacy will remain for years to come!
Clinicians, researchers, health tech innovators, engineers and data experts have been working together since the project began in January 2021 with one clear goal in mind: to develop a Federated Learning platform built on clinical data and powered by novel AI models to advance precision medicine in hematology.
After a journey of 4.5 years, our EU-funded initiative draws its curtain on a high note, celebrating the achievements jointly made by the 23 partner institutions from Spain, Italy, Germany, France, Cyprus, Greece and Denmark.
We’d like to express our gratitude to the full GenoMed4All consortium for their efforts in these last years, and also to the European Health and Digital Executive Agency (HaDEA), ERN-EuroBloodNet and many others for their invaluable support!
Upon reaching the final stages, we asked some of the minds behind the project to reflect on the lasting impact of the work carried within the context of GenoMed4All. This is what they had to say.